A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
The new micro-device for fluid analysis will enable more tailored experiments in drug development and disease research.
It could also transform water contamination testing and medical diagnosis in natural disaster zones, where its low cost, simple use and portability make it a practical tool almost anyone can use.
How it works
Microfluidic or ‘lab-on-a-chip’ devices are commonly used to analyse blood and other fluid samples, which are pumped through narrow channels in a transparent chip the size of a postage stamp.
These miniaturised chips are made using state-of-the-art device fabrication facilities at RMIT’s Micro Nano Research Facility.
This new chip takes that technology one step further by adding a three-dimensional cavity along the channel – think of a narrow tunnel that suddenly opens into a domed vault – which creates a mini-vortex where particles spin around, making them easier to observe.
To make this cavity, researchers inserted a liquid metal drop onto the silicon mould when making the chip.
The liquid metal’s high surface tension means it holds its form during the moulding process.
Finally the liquid metal is removed, leaving just the channel and a spherical cavity ready to use as a mini-centrifuge, explained RMIT engineer and study co-leader Dr Khashayar Khoshmanesh.
“When the fluid sample enters the spherical-shaped cavity, it spins inside the cavity,” he said.
“This spinning creates a natural vortex, which just like a centrifuge machine in an analytics lab, spins the cells or other biological samples, allowing them to be studied without the need for capturing or labelling them.”
The device only requires tiny samples, as little as 1 ml of water or blood, and can be used to study tiny bacterial cells measuring just 1 micron, all the way up to human cells as large as 15 microns.
A platform for studying cardiovascular diseases
Study co-leader and RMIT Postdoctoral Research Fellow, Dr Sara Baratchi, said the device’s soft spherical cavities could be used to mimic 3D human organs and observe how cells behave in various flow conditions or drug interactions.
“The ability to tailor the size of the cavity also allows for different flow situations to be simulated – this way we can mimic the response of blood cells under disturbed flow situations, for example at branch points and curvatures of coronary and carotid arteries, which are more prone to narrowing,” she said.
This capability will be of interest to Australia’s booming biomedical industry, with medical apparatus being among our top 10 exports in 2018 and worth $3.2 billion.
Baratchi said the discovery was only made possible through collaboration, with technologists from the School of Engineering and mechano-biologists in the School of Health and Biomedical Sciences joining forces in RMIT’s Mechanobiology and Microfluidics research group.
“Biologists like myself have been struggling to study the impact of flow-associated forces on circulatory blood cells. Now this miniaturised device developed with our engineering colleagues does exactly that,” Baratchi said.
“It’s an ingenious solution that really highlights the value of cross-disciplinary research.”
But some of the most exciting applications could also be outside the lab.
A cheap and portable water test that anyone can use
Another promising application is for identifying parasites and other infections in waterways, especially in developing countries.
“Detection of water impurities can be a difficult task because you don’t always know exactly what you’re looking for,” Khoshmanesh said.
“But with this device the impurities will be captured and orbited by the vortex without any special sample preparation, saving time and money.”
Whether used for analysing water or blood samples, the low cost and portability of the device makes it attractive for a whole range of applications.
The same research group recently developed a pressure pump, made from latex balloons, to operate the device.
Unlike conventional pumps, which can be as large as a shoebox and cost thousands of dollars, theirs is low cost and portable.
“Simplicity is a very important parameter for our designs because that often translates to lower cost and great applicability outside the lab,” Khoshmanesh said.
“Our new microfluidic device, combined with our pump and a smartphone capable of capturing high-speed images, makes a low-cost, self-sufficient and entirely portable point-of-care diagnostics device.”
The Latest on: Point-of-care diagnostics device
via Google News
The Latest on: Point-of-care diagnostics device
- In Vitro Diagnostics (IVD) Market Expected to Reach $91 Billion by 2027on January 20, 2021 at 10:49 am
Demand for in vitro diagnostics is on therise owing to surge in prevalence of various chronic diseases such as diabetes cancer and liver diseases which require the use of IVD tests for diagnosis ...
- Microfluidic Devices Market Growth, Opportunities and Demand with Competitive Landscape and Analysis Research Report 2021 – 2024on January 20, 2021 at 5:36 am
Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 ...
- Why Chicago Is Emerging An AI-Life Sciences Leaderon January 20, 2021 at 5:35 am
Chicago is becoming a world leader in a new frontier of precision medicine. And with continued momentum from Chicago-based academic research, venture funded startups and established enterprises—we can ...
- Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.on January 19, 2021 at 10:07 pm
PRNewswire/ -- Hillrom (NYSE: HRC) today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ...
- Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotechon January 19, 2021 at 5:57 am
Thermo Fisher Scientific Inc. the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic ...
- DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologieson January 18, 2021 at 6:45 pm
Mammoth Biosciences will apply its DETECTR™ platform, and IDbyDNA, its proprietary pathogen database and algorithms, toward the development of CRISPR-based diagnostics and biosurveillance technologies ...
- i-calQ’s Smartphone-based diagnostic platform makes rapid testing easy, fast, and inexpensiveon January 14, 2021 at 10:00 am
A new smartphone technology developed by i-calQ, a leader in the emerging mobile bio-diagnostics industry, promises to deliver easy to use, fast and inexpensive point of care diagnostics that will ...
- Global Point-of-care Cholesterol Monitoring Device Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2028on January 12, 2021 at 5:33 pm
A recent market study published by the company “Point-of-care Cholesterol Monitoring Device Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” consists a comprehensive ...
- Israeli blood diagnostic solution expands into Scandinaviaon January 12, 2021 at 5:40 am
The Israeli startup kicks off 2021 on a high note, launching point-of-care diagnostic solution in Sweden... Israeli MedTech startup PixCell Medical and its blood-based diagnostic device at ...
- Global Point-of-Care Diagnostics Market Growth, Trends and Forecasts to 2025 - ResearchAndMarkets.comon January 8, 2021 at 7:00 am
The "Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The point-of-care diagnostics market is expected to ...
via Bing News